RS50433B - Postupak za dobijanje i upotreba sfernih klastera telitromicina za pripremanje farmaceutskih oblika - Google Patents

Postupak za dobijanje i upotreba sfernih klastera telitromicina za pripremanje farmaceutskih oblika

Info

Publication number
RS50433B
RS50433B YUP-132/02A YUP13202A RS50433B RS 50433 B RS50433 B RS 50433B YU P13202 A YUP13202 A YU P13202A RS 50433 B RS50433 B RS 50433B
Authority
RS
Serbia
Prior art keywords
telithromycin
obtaining
clusters
procedure
telythromycine
Prior art date
Application number
YUP-132/02A
Other languages
English (en)
Serbian (sr)
Inventor
Jean-Yves Godard
Valérie ROGNON-RAVAUX
Original Assignee
Aventis Pharma S.A.,
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=9549351&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=RS50433(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Aventis Pharma S.A., filed Critical Aventis Pharma S.A.,
Publication of YU13202A publication Critical patent/YU13202A/sh
Publication of RS50433B publication Critical patent/RS50433B/sr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1682—Processes
    • A61K9/1688—Processes resulting in pure drug agglomerate optionally containing up to 5% of excipient
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Communicable Diseases (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
YUP-132/02A 1999-08-26 2000-08-28 Postupak za dobijanje i upotreba sfernih klastera telitromicina za pripremanje farmaceutskih oblika RS50433B (sr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9910810A FR2797875B1 (fr) 1999-08-26 1999-08-26 Agglomerats spheriques de telithromycine, leur procede de preparation et leur application dans la preparation de formes pharmaceutiques

Publications (2)

Publication Number Publication Date
YU13202A YU13202A (sh) 2004-09-03
RS50433B true RS50433B (sr) 2009-12-31

Family

ID=9549351

Family Applications (1)

Application Number Title Priority Date Filing Date
YUP-132/02A RS50433B (sr) 1999-08-26 2000-08-28 Postupak za dobijanje i upotreba sfernih klastera telitromicina za pripremanje farmaceutskih oblika

Country Status (34)

Country Link
US (1) US6825218B1 (enExample)
EP (1) EP1212336B1 (enExample)
JP (1) JP4871467B2 (enExample)
KR (1) KR100718222B1 (enExample)
CN (1) CN1183151C (enExample)
AR (1) AR025398A1 (enExample)
AT (1) ATE255590T1 (enExample)
AU (1) AU774385B2 (enExample)
BR (1) BR0013569B1 (enExample)
CA (1) CA2382497C (enExample)
CO (1) CO5190666A1 (enExample)
CZ (1) CZ2002594A3 (enExample)
DE (1) DE60006976T2 (enExample)
DK (1) DK1212336T3 (enExample)
EA (1) EA005080B1 (enExample)
ES (1) ES2209970T3 (enExample)
FR (1) FR2797875B1 (enExample)
HK (1) HK1049167B (enExample)
HR (1) HRP20020167B1 (enExample)
HU (1) HU229075B1 (enExample)
IL (2) IL148128A0 (enExample)
ME (2) ME00112B (enExample)
MX (1) MXPA02001988A (enExample)
NO (1) NO322622B1 (enExample)
PL (1) PL204100B1 (enExample)
PT (1) PT1212336E (enExample)
RS (1) RS50433B (enExample)
SI (1) SI1212336T1 (enExample)
SK (1) SK287588B6 (enExample)
TR (1) TR200200506T2 (enExample)
TW (1) TWI272949B (enExample)
UA (1) UA73523C2 (enExample)
WO (1) WO2001014393A2 (enExample)
ZA (1) ZA200201599B (enExample)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9902202D0 (sv) * 1999-06-10 1999-06-10 Astra Ab Production of aggregates
FR2821747B1 (fr) * 2001-03-09 2004-07-02 Ethypharm Lab Prod Ethiques Suspension de telithromycine a gout masque
BR0215806A (pt) * 2002-07-19 2005-04-26 Aventis Pharma Sa Composição oral de telitromicina com paladar mascarado
US20040013737A1 (en) * 2002-07-19 2004-01-22 Philippe Becourt Taste masked oral composition of telithromycin
WO2004009059A1 (en) * 2002-07-19 2004-01-29 Aventis Pharma S.A. Taste masked oral composition of telithromycin
CA2516733C (en) * 2003-02-21 2011-09-27 The University Of Bath Process for the production of particles
US20050014706A1 (en) * 2003-07-14 2005-01-20 Kanakeshwari Falzari Method of treating tuberculosis
WO2007039914A2 (en) * 2005-10-06 2007-04-12 Alembic Limited Novel polymorphs of telithromycin
US20090075917A1 (en) * 2007-09-19 2009-03-19 Protia, Llc Deuterium-enriched telithromycin
KR101324862B1 (ko) * 2011-07-12 2013-11-01 (주)에이에스텍 클로피도그렐 황산수소염의 구형 입자, 이를 포함하는 약학적 조성물 및 이의 제조방법

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3468336D1 (en) * 1983-06-22 1988-02-11 Univ Ohio State Res Found Small particle formation
JPH02227130A (ja) * 1989-02-28 1990-09-10 Taisho Pharmaceut Co Ltd 球形微小凍結粒子の製造法
FR2719587B1 (fr) * 1994-05-03 1996-07-12 Roussel Uclaf Nouveaux dérivés de l'érythromycine, leur procédé de préparation et leur application comme médicaments.

Also Published As

Publication number Publication date
ME00112B (me) 2010-10-10
HK1049167B (zh) 2005-08-19
NO322622B1 (no) 2006-11-06
EP1212336B1 (fr) 2003-12-03
KR20020033771A (ko) 2002-05-07
HRP20020167B1 (en) 2006-06-30
HRP20020167A2 (en) 2003-06-30
CN1183151C (zh) 2005-01-05
YU13202A (sh) 2004-09-03
DK1212336T3 (da) 2004-03-15
BR0013569B1 (pt) 2014-02-25
SK2532002A3 (en) 2002-09-10
EA200200294A1 (ru) 2002-08-29
NO20020926L (no) 2002-02-26
WO2001014393A2 (fr) 2001-03-01
FR2797875B1 (fr) 2001-10-19
JP2003507484A (ja) 2003-02-25
HK1049167A1 (en) 2003-05-02
CZ2002594A3 (cs) 2002-09-11
TR200200506T2 (tr) 2002-08-21
AR025398A1 (es) 2002-11-27
AU774385B2 (en) 2004-06-24
US6825218B1 (en) 2004-11-30
IL148128A (en) 2006-10-31
TWI272949B (en) 2007-02-11
PL204100B1 (pl) 2009-12-31
AU7018100A (en) 2001-03-19
ATE255590T1 (de) 2003-12-15
CN1371386A (zh) 2002-09-25
HUP0202842A2 (hu) 2003-01-28
EP1212336A2 (fr) 2002-06-12
HUP0202842A3 (en) 2003-03-28
MEP20108A (en) 2010-06-10
KR100718222B1 (ko) 2007-05-15
ES2209970T3 (es) 2004-07-01
CA2382497A1 (fr) 2001-03-01
ZA200201599B (en) 2003-04-30
CO5190666A1 (es) 2002-08-29
CA2382497C (fr) 2011-06-28
JP4871467B2 (ja) 2012-02-08
DE60006976D1 (de) 2004-01-15
WO2001014393A3 (fr) 2001-06-21
MXPA02001988A (es) 2002-08-20
SI1212336T1 (en) 2004-04-30
PT1212336E (pt) 2004-04-30
BR0013569A (pt) 2002-05-14
SK287588B6 (sk) 2011-03-04
PL353137A1 (en) 2003-10-20
EA005080B1 (ru) 2004-10-28
IL148128A0 (en) 2002-09-12
UA73523C2 (uk) 2005-08-15
DE60006976T2 (de) 2004-10-21
NO20020926D0 (no) 2002-02-26
HU229075B1 (hu) 2013-07-29
FR2797875A1 (fr) 2001-03-02

Similar Documents

Publication Publication Date Title
US5077051A (en) Sustained release of active agents from bioadhesive microcapsules
JPS60116627A (ja) 脈管内輸送用微小球の製法
JP2003530996A (ja) ゼロ次放出を示す、温度制御されたマイクロカプセル並びにその調整方法
JPH07508509A (ja) 微粒剤の形態の胃保護された安定なオメプラゾール組成物およびその製造方法
JPH09500093A (ja) 高放出性固体製剤、その製法および用途
BR112013006381B1 (pt) Composição que compreende um material de núcleo tendo um valor de sabor e um revestimento polimérico e formulação farmacêutica
HK79791A (en) Solid galenical forms for oral application containing 9-deoxo-11-deoxy-9,11-(imino(2-(2-methoxyethoxy)ethyliden)-oxy)-(9s)-erythromycin, and process for their preparation
DE102004012273A1 (de) Stabile und geschmacksmaskierte pharmazeutische Dosierungsform unter Verwendung von porösen Apatit-Körnern
SE466047B (sv) Partikelformig komposition av cefuroxim-axetil daer partiklarna oeverdragits med lipider samt foerfarande foer dess framstaellning
US20130202713A1 (en) Coating of particles comprising a pharmaceutically active ingredient with a carbonate salt or phosphate salt
DK157730B (da) Fremgangsmaade til fremstilling af et farmaceutisk mikrokapselpraeparat og praeparat fremstillet ved fremgangsmaaden
JP2001523706A (ja) スフェロイド、製造方法および医薬組成物
RS50433B (sr) Postupak za dobijanje i upotreba sfernih klastera telitromicina za pripremanje farmaceutskih oblika
PL194527B1 (pl) Powlekane cząsteczki krystalicznego ibuprofenu oraz sposób ich wytwarzania
CN1525852B (zh) 被掩味的包衣颗粒和粒状物
US4442051A (en) Encapsulation of indomethacin
CA1139225A (en) Stable valepotriate compounds and process for their preparation
JP2004277431A (ja) 粒状製剤及びその製造法
Narkhede et al. Formulation and evaluation of tetracycline hydrochloride microcapsules by solvent evaporation method
HU184080B (en) Process for preparing microcapsules
HK1068059B (zh) 被掩味的包衣颗粒和粒状物